Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Lack of Association between Chlamydia trachomatis Infection and Cervical Cancer - Taq Man Realtime PCR Assay Findings

  • Farivar, Taghi Naserpour (Cell and Molecular Research Center, Qazvin University of Medical Sciences) ;
  • Johari, Pouran (Cell and Molecular Research Center, Qazvin University of Medical Sciences)
  • Published : 2012.08.31
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Cervical cancer is one of the most common cancers in developing countries and the second most common type of cancer in women globally. Several recent studies suggested a co factor role for Chlamydia trachomatis in pathogenesis of cervical cancer. This study aimed to evaluate existence of C. trachomatis DNA in pathologic blocks of patients with cervical cancer. Materials and methods: Seventy-six formaldehyde fixed paraffin embedded tissue specimens from patients with histologically proven history of cervical cancer as well as 150 blocks from healthy peoples were included in the present study. Thin slices were prepared from selected blocks followed by deparaffinization and DNA extraction; the presence of C. trachomatis DNA was examined by Taq Man real-time PCR. Results: Our TaqMan real time PCR assay with cervical specimens of patients with cervical cancer showed that there was no C. trachomatis DNA. Also, we found three positive specimens among our control group. Conclusion: It seems that based on results obtained from the specimens examined in the present study, there is no association between the presence of C. trachomatis DNA in cervical specimens and cervical cancer.

Keywords

References

  1. Anonymous (2010). Disease Control and Prevention, and National Cancer Institute (2010). Available at:http://www.cdc.gov/uscs.
  2. Bosch FX, de Sanjosé S (2007). The epidemiology of human papillomavirus infection and cervical cancer. Dis Markers, 23, 213-27. https://doi.org/10.1155/2007/914823
  3. Carozzi F, Ronco G, Gillio-Tos A, et al (2012). Concurrent infections with multiple human papillomavirus (HPV) types in the New Technologies for Cervical Cancer (NTCC) screening study, Working Group. Eur J Cancer, 48, 1633-7. https://doi.org/10.1016/j.ejca.2011.10.010
  4. Castle PE, Escoffery C, Schachter J, et al (2003). Chlamydia trachomatis, herpes simplex virus 2, and human T-cell lymphotrophic virus type 1 are not associated with grade of cervical neoplasia in Jamaican colposcopy patients. Sex Transm Dis, 30, 575-80. https://doi.org/10.1097/00007435-200307000-00009
  5. Dahlstrom LA, Andersson K, Luostarinen T, et al (2011). Prospective Seroepidemiologic Study of Human Papillomavirus and Other Risk Factors in Cervical Cancer. Cancer Epidemiol Biomarkers Prev, 20, 2541-50. https://doi.org/10.1158/1055-9965.EPI-11-0761
  6. Daling JR, Madeleine MM, McKnight B, et al (1996). The relationship of human papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection. Cancer Epidemiol Biomarkers Prev, 5, 541-8.
  7. Deluca GD, Marin HM, Schelover E, et al (2006). Chlamydia trachomatis and papillomavirus infection in women with cytohistological abnormalities in uterine cervix. Medicina (B Aires), 66, 303-6.
  8. Du P, Lemkin A, Kluhsman B, et al (2010). The roles of social domains, behavioral risk, health care resources, and chlamydia in spatial clusters of US cervical cancer mortality: not all the clusters are the same. Cancer Causes Control, 21, 1669-83. https://doi.org/10.1007/s10552-010-9596-4
  9. Farivar TN, Johari P, Shafei S, et al (2012). Lack of association between herpes simplex virus type 2 infection and cervical cancer-Taq Man Real-time PCR assay findings. Asian Pac J Cancer Prev, 13, 339-42. https://doi.org/10.7314/APJCP.2012.13.1.339
  10. Finan RR, Musharrafieh U, Almawi WY, et al (2006). Detection of Chlamydia trachomatis and herpes simplex virus type 1 or 2 in cervical samples in human papilloma virus (HPV)-positive and HPV-negative women. Clin Microbiol Infect, 12, 927-30. https://doi.org/10.1111/j.1469-0691.2006.01479.x
  11. Jensen KE, Munk C, Sparen P, et al (2011). Women's sexual behavior.Population-based study among 65,000 women from four Nordic countries before introduction of human papillomavirus vaccination. Acta Obstet Gynecol Scand, 90, 459-67. https://doi.org/10.1111/j.1600-0412.2010.01066.x
  12. Klomp JM, Boon ME, Dorman MZ, (2010). Trends in inflammatory status of the vaginal flora as established in the Dutch national screening program for cervical cancer over the last decade. Acta Cytol, 54, 43-9 https://doi.org/10.1159/000324965
  13. Kwasniewska A, Korobowicz E, Zdunek M, et al (2009). Prevalence of Chlamydia trachomatis and herpes simplex virus 2 in cervical carcinoma associated with human papillomavirus detected in paraffin-sectioned samples. Eur J Gynaecol Oncol, 30, 65-70.
  14. Madeleine MM, Anttila T, Schwartz SM, et al (2007). Risk of cervical cancer associated with Chlamydia trachomatis antibodies by histology, HPV type and HPV cofactors. Int J Cancer, 120, 650-5. https://doi.org/10.1002/ijc.22325
  15. Magaldi TG, Almstead LL, Bellone S, et al (2012). Primary human cervical carcinoma cells require human papillomavirus E6 and E7 expression for ongoing proliferation. Virology, 5, 114-24.
  16. Menczer J (2003) The low incidence of cervical cancer in Jewish women: Has the Puzzle Finally Been Solved?, 5,120-12
  17. Miller WC, Ko EM, ONE AUTHOR, et al (2011). Does chlamydial infection increase the risk of cervical dysplasia? Sex Transm Infect, 87, 366-7 https://doi.org/10.1136/sti.2011.049775
  18. Naserpour Farivar T, Johari P, Pahlavan AA, et al (2012). Agreement rate of rapid urease test, conventional PCR, and Scorpion real-time PCR in detecting Helicobacter pylori from tonsillar samples of patients with chronic tonsillitis. J Glob Infect Dis, 4, 38-42. https://doi.org/10.4103/0974-777X.93760
  19. Naucler P, Chen HC, Persson K, et al (2007). Seroprevalence of human papillomaviruses and Chlamydia trachomatis and cervical cancer risk: nested case-control study. J Gen Virol, 88, 814-22. https://doi.org/10.1099/vir.0.82503-0
  20. Paavonen J, Karunakaran KP, Noguchi Y, et al (2003). Serum antibody response to the heat shock protein 60 of Chlamydia trachomatis in women with developing cervical cancer. Am J Obstet Gynecol, 189, 1287-92. https://doi.org/10.1067/S0002-9378(03)00755-5
  21. Quint, KD, de Koning MNC, Geraets DT, et al (2009) Comprehensive analysis of Human Papillomavirus and Chlamydia trachomatis in in-situ and invasive cervical adenocarcinoma. Gynecologic Oncology, 114, 390-4 https://doi.org/10.1016/j.ygyno.2009.05.013
  22. Safaeian M, Quint K, Schiffman M, et al (2010). Chlamydia trachomatis and risk of prevalent and incident cervical premalignancy in a population-based cohort. J Natl Cancer Inst, 102, 1794-804. https://doi.org/10.1093/jnci/djq436
  23. Samoff E, Koumans EH, Markowitz EL, et al (2005). association of chlamydia trachomatis with persistence of high-risk types of human papillomavirus in a cohort of female adolescents. Am J Epidemiol, 162, 668-75. https://doi.org/10.1093/aje/kwi262
  24. Saveleva NV, Zagryadskaya YE, Klimashevskaya SV, et al (2010). Scanning diagnostically significant antigenic regions of major Chlamydia trachomatis protein MOMP using series of overlapping recombinant proteins. Molecular Genetics. Microbiology and Virology, 24, 133-7.
  25. Simonetti AC, Melo JH, de Souza PR, et al (2009). Immunological's host profile for HPV and Chlamydia trachomatis, a cervical cancer cofactor. Microbes Infect, 11, 435-42. https://doi.org/10.1016/j.micinf.2009.01.004
  26. Smith JS, Bosetti C, Munoz N, et al (2004). Chlamydia trachomatis and invasive cervical cancer: a pooled analysis of the IARC multicentric case-control study.IARC multicentric case-control study. Int J Cancer, 111, 431-9. https://doi.org/10.1002/ijc.20257
  27. Steben M, Duarte-Franco E (2007). Human papillomavirus infection: epidemiology and pathophysiology. Gynecol Oncol, 107, 2-5. https://doi.org/10.1016/j.ygyno.2007.08.078
  28. Valadan M, Yarandi F, Eftekhar Z, et al (2010). Chlamydia trachomatis and cervical intraepithelial neoplasia in married women in a Middle Eastern community. East Med Health J, 16, 304-7.
  29. Vidal AC, Murphy SK, Hernandez BY, et al (2011). Distribution of HPV genotypes in cervical intraepithelial lesions and cervical cancer in Tanzanian women. InfectAgent Cancer, 14, 20-5.
  30. Wallin KL,Wiklund F,Luostarinen T, et al (2002) A populationbased prospective study of Chlamydia trachomatis infection and cervical carcinoma. Inter J Cancer, 101, 371-4. https://doi.org/10.1002/ijc.10639
  31. Zereu M, Zettler CG, Cambruzzi E, et al (2007) Herpes simplex virus type 2 and Chlamydia trachomatis in adenocarcinoma of the uterine cervix. Gynecol Oncol, 105, 172-5. https://doi.org/10.1016/j.ygyno.2006.11.006

Cited by

  1. Lack of Significant Effects of Chlamydia trachomatis Infection on Cervical Cancer Risk in a Nested Case-Control Study in North-East Thailand vol.15, pp.3, 2014, https://doi.org/10.7314/APJCP.2014.15.3.1497
  2. Comparison of Two Methods to Extract DNA from Formalin-Fixed, Paraffin-Embedded Tissues and their Impact on EGFR Mutation Detection in Non-small Cell Lung Carcinoma vol.15, pp.6, 2014, https://doi.org/10.7314/APJCP.2014.15.6.2733
  3. Up-regulation of Transcription Factor 3 Is Correlated With Poor Prognosis in Cervical Carcinoma vol.27, pp.7, 2017, https://doi.org/10.1097/IGC.0000000000001032
  4. Chlamydia Trachomatis Infection-Associated Risk of Cervical Cancer vol.95, pp.13, 2016, https://doi.org/10.1097/MD.0000000000003077
  5. A PRISMA systematic review and meta-analysis on Chlamydia trachomatis infections in Iranian women (1986–2015) vol.97, pp.16, 2018, https://doi.org/10.1097/MD.0000000000010335